Assessing Cardiac Safety in Oncology Drug Development

Based on a Cardiac Safety Research Consortium Think Tank held in October 2017 on “Detection, Assessment, and Risk Mitigation of Cardiac Safety Signals in Oncology Drug Development, this publication discusses emerging cardio-oncology nuances and the latest regulatory thinking on ways to manage risks. 

No Previous Flipbooks

Next Flipbook
Q&A: The Role of Expert Committees and the Regulatory Landscape
Q&A: The Role of Expert Committees and the Regulatory Landscape

Dr. Seltzer, president and founder of ACI Clinical, and chief scientific officer of WCG Clinical, shared hi...